| Literature DB >> 35308451 |
Nooshin Mohtasham1,2, Nasrollah Saghravanian2, Reza Zare1,2, Shadi Saghafi2, Narges Ghazi2, Farnaz Mohajertehran1,2, Mehdi Shahabinejad2.
Abstract
Background: The associations between Helicobacter pylori and human papillomavirus (HPV) with head and neck squamous cell carcinomas (HNSCCs) are approved before. However, the association between demographic, clinicopathological, and histologic characteristics of HNSCC patients and molecular detection of HPV and H. pylori has not been enough investigated. Materials andEntities:
Keywords: Grade; Helicobacter pylori; head and neck squamous cell carcinoma; human papillomavirus; stage
Year: 2022 PMID: 35308451 PMCID: PMC8927946 DOI: 10.4103/1735-3327.336693
Source DB: PubMed Journal: Dent Res J (Isfahan) ISSN: 1735-3327
Primers set and conditions used for Helicobacter pylori and human papillomavirus detection by polymerase chain reaction method in this study
| Genes | Nucleotide sequence(5’-3’) | PCR product | PCR conditions | Reference |
|---|---|---|---|---|
|
| 5’-GCGACCTGCTGGAACATTAC-3’ | 138 bp | 95°C, 55 s; 59°C, 55s | [ |
|
| 5’AAGCTTTTAGGGGTGTTAGGGGTTT-3’ | 294 bp | 95°C, 55s; 57°C, 55 s | [ |
|
| 5’CGTCCMARRGGAWACTGATC 3’ | 450 pb | 94°C, 45 s; 55°C, 45 s | [ |
|
| 5’GCMCAGGGWCATAAYAATGG 3’ | 72°C, 45 s(40cycles) |
PCR: Polymerase chain reaction
Clinicopathological characteristics of 62 patients with head and neck squamous cell
| Variable | |
|---|---|
| Gender | |
| Male | 47 (75.8) |
| Female | 15 (24.2) |
| Age (60.5±13.4years) | |
| ≥60.5 | 31 (50.0) |
| <60.5 | 31 (50.0) |
| Clinical staging(TMN) | |
| Early | 28 (45.2) |
| Advanced | 34 (54.8) |
| Histopathological grade | |
| I | 38 (61.3) |
| II | 20 (32.2) |
| III | 4 (6.5) |
| Tumor position | |
| Lip | 13 (20.9) |
| Tongue and oral cavity | 17 (27.4) |
| Larynx | 26 (41.9) |
| Nasal cavity | 3 (4.8) |
| Ear canal | 3 (4.8) |
| Family history cancer | |
| Yes | 13 (20.9) |
| No | 49 (79.1) |
| History of gastric reflux | |
| Yes | 23 (37.1) |
| No | 39 (62.9) |
| Smoking | |
| Daily | 21 (33.9) |
| No | 41(66.1) |
| Alcohol | |
| Daily | 5 (8.1) |
| No | 57 (91.9) |
| Opiate use | |
| Yes | 28 (45.2) |
| No | 34 (54.8) |
TMN: Tumor node metastasis
Relation of clinicopathological and demographic characteristics with histopathological stage
| Variables | Overall | Participants, |
| |
|---|---|---|---|---|
|
| ||||
| Early stage | Advanced stage | |||
| Histopathological grade | ||||
| Well (I) | 38 | 23 (82.1) | 15 (44.1) | 0.003* |
| Moderate (II) | 20 | 5 (17.9) | 15 (44.1) | |
| Poor (III) | 4 | 0 | 4 (11.8) | |
| Lymph node involvement | ||||
| Yes | 29 | 9 (32.1) | 20 (58.8) | 0.03* |
| No | 33 | 19 (67.9) | 14 (41.2) | |
| Alcohol | ||||
| Daily | 7 | 1 (3.6) | 6 (17.6) | 0.12 |
| No | 55 | 27 (96.4) | 28 (82.4) | |
| Opiate use | ||||
| Yes | 28 | 12 (42.8) | 16 (47.1) | 0.8 |
| No | 34 | 16 (57.2) | 18 (52.9) | |
| Smoking | ||||
| Daily | 21 | 9 (32.2) | 22 (64.7) | 0.79 |
| No | 41 | 19 (67.8) | 12 (35.3) | |
| Gender | ||||
| Female | 15 | 7 (25.0) | 8 (23.5) | 0.56 |
| Male | 47 | 21 (75.0) | 26 (76.5) | |
| Age, years old | ||||
| ≥60.5 | 31 | 15 (53.6) | 16 (47.1) | 0.79 |
| <60.5 | 31 | 13 (46.4) | 18 (52.9) | |
| Tumor position | ||||
| Lip | 13 | 7 (73.8) | 6 (46.2) | 0.42 |
| Tongue and oral cavity | 17 | 6 (35.3) | 11 (64.7) | |
| Larynx | 26 | 13 (50.0) | 13 (50.0) | |
| Nasal cavity | 3 | 2 (66.7) | 1 (33.3) | |
| Ear canal | 3 | 0 (0.0) | 3 (100.0) | |
Numbers in the parenthesis showed percentage of studied patients in each related variable. *Analyses were performed under Chi-square test. P<0.05 considered as significant level
Figure 1Relation of histopathological grade and molecular detection of Helicobacter pylori (a) and human papillomavirus (b) in tumor tissue and healthy margin tissue. Analyses were performed under Chi-square test.
Characteristics of head and neck squamous cell carcinoma tumor tissues and Helicobacter pylori and human papillomavirus status
| Variables |
| HPV | |||||
|---|---|---|---|---|---|---|---|
|
|
| ||||||
|
| HPV+ ( | HPV− ( |
| ||||
| Gender | |||||||
| Male | 47(76) | 16(80) | 31(74) | 0.75 | 6(75) | 41(76) | 1.00 |
| Female | 15(24) | 4(20) | 11(26) | 2(25) | 13(24) | ||
| Age, years old | |||||||
| ≥60.5 | 31(50) | 7(35) | 24(57) | 0.10 | 1(12.55) | 30(56) | 0.05* |
| <60.5 | 31(50) | 13(65) | 18(43) | 7(87.5) | 24(44) | ||
| Tumor position | |||||||
| Lip | 13(20) | 5(8.06) | 8(12.90) | 0.57 | 1(1.61) | 12(19.35) | 0.91 |
| Tongue and oral cavity | 17(27) | 7(11.29) | 10(16.12) | 3(4.83) | 14(22.58) | ||
| Larynx | 26(41.93) | 8(12.90) | 18(29.03) | 4(6.45) | 22(35.48) | ||
| Nasal cavity | 3(4.83) | 0 | 3(4.83) | 0 | 3(4.83) | ||
| Ear canal | 3(4.83) | 0 | 3(4.83) | 0 | 3(4.83) | ||
| Grade | |||||||
| Well(I) | 38(61.29) | 13(20) | 25(40.32) | 0.55 | 1(1.61) | 37(59.67) | 0.001* |
| Moderate(II) | 20(32.25) | 5(8.06) | 15(24.19) | 3(4.83) | 17(27.41) | ||
| Poor(III) | 4(6.45) | 2(3.22) | 2(3.22) | 4(6.45) | 0 | ||
| Stage | |||||||
| Early | 28(45.16) | 8(12.9) | 20(32.25) | 0.57 | 1(1.61) | 27(43.54) | 0.063 |
| Advanced | 34(54.83) | 12(19.35) | 22(35.48) | 7(11.29) | 27(43.54) | ||
| Alcohol | |||||||
| Daily | 7(11.29) | 3(4.83) | 4(6.45) | 0.12 | 1(1.61) | 6(9.67) | |
| No | 55(88.70) | 17(27.41) | 38(61.29) | 7(11.29) | 48(77.41) | ||
| Opiate use | |||||||
| Yes | 28(45.16) | 8(12.90) | 20(32.25) | 0.57 | 6(9.67) | 22(35.48) | 0.12 |
| No | 34(54.83) | 12(19.35) | 22(35.48) | 2(3.22) | 32(51.61) | ||
| Smoking | |||||||
| Daily | 21(33.87) | 7(11.29) | 14(22.58) | 0.89 | 1(1.61) | 20(32.25) | 0.24 |
| No | 41(66.12) | 13(20) | 28(45.16) | 7(11.29) | 34(54.83) | ||
Numbers in the parenthesis showed percentage of studied patients in each related variable. *Analyses were performed under Chi-square test. P<0.05 considered as significant level. H. pylori: Helicobacter pylori; HPV: Human papillomavirus